Oct 22, 2018 - Panel presentation including by BRI Executive Chairman Don Tapscott, Hyperledger Executive Director Brian Behlendorf, and FedEx VP of Strategic Planning and Support Dale Chrystie. At the BRI Spring 2018 All-Member Summit, the panel explored how permissioned blockchains will affect enterprise, and how IBM's Hyperledger, and FedEx, are innovating within the blockchain space.

May 01, 2021 - Blockchain Research Institute Executive Chairman Don Tapscott moderated a panel discussion of digital identity—the self-sovereign identity, verifiable credentials, immunity passports, blockchain-based wallets, and more—featuring Brian Behlendorf, general manager for blockchain, healthcare, and identity at the Linux Foundation and executive director of Hyperledger; Stephen Curran, a principal of Cloud Compass Computing and a software developer and DevOps veteran; and Nathan George, senior director of engineering for the protocol team at Kiva Microfunds. This is an edited transcript of their candid conversation.

Feb 17, 2022 - The value of blockchain innovation comes from outward-looking strategies that benefit from broad collaboration across an ecosystem, especially around standards. But the legacy systems and processes of the automotive industry tend to favor incremental change over bold transformation. Without reliable estimates of eventual returns, many automakers have hesitated to invest in open experimentation. This new paper provides a framework for understanding the potential of distributed ledger technologies in mobility and transportation. It presents two dozen of most important blockchain use cases for automotive in three categories—enterprise operatio...

Apr 07, 2020 - This hour-long webinar is part one in a four-part series on blockchain and pandemics. Don Tapscott opens with an overview of blockchain's applicability in the current COVID-19 crisis, which is followed by a discussion between Brian Behlendorf from the Hyperledger Foundation, Heather Flannery from ConsenSys Health, and David Jaffray from the MD Anderson Cancer Center.